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The number of carotid endarterectomy (CEA)
procedures performed in the United States has risen
dramatically during recent years. After a rate of
decline through the late 1980s, the number of CEA
procedures rose 94% from 1991 to 1996, when an
estimated 130,000 CEAs were performed nation-
wide.1 Although a portion of this increase may be
explained by the aging population, most authors
agree that the more dramatic recent rise is due to the
highly publicized series of clinical trials. These stud-
ies showed that for stroke prevention in sympto-
matic and asymptomatic patients with carotid bifur-
cation stenosis, CEA is the preferred treatment
when carried out in centers with nominal stroke and
death rates.2-6
The institutions and the surgeons who took part
in these trials were carefully selected to optimize the
results of surgery.2,3 Surgical case load and operative
stroke and death rates were scrutinized before both
surgeon and center were allowed to participate. The
patients were also carefully selected; large numbers
were screened to enroll just a small portion. Both
the North American Symptomatic Carotid
Endarterectomy Trial (NASCET) and the
Carotid endarterectomy: Characterization
of recent increases in procedure rates
Mark D. Morasch, MD, Michele A. Parker, RN, MS, Joe Feinglass, PhD,
Larry M. Manheim, PhD, and William H. Pearce, MD, Chicago, Ill
Introduction: Recent increases in the rate of carotid endarterectomies (CEAs) have been
attributed to results of clinical trials demonstrating efficacy when CEA is performed in
centers of excellence. Subsequent population-based data suggest that trial results may
not be matched in the community. This study was undertaken to characterize trends in
CEA procedure rates after the dissemination of trial data and to describe any change in
patient outcomes with population-based data from a single state.
Methods: Hospital administrative data on CEAs from 1992 to 1996 (n = 45,744) were
obtained for the state of Florida. Annualized CEA rates per 100,000 Florida residents
were analyzed to determine trends in patient age, sex, admission type, size of hospital
beds, ownership type and teaching status, and annual hospital and surgeon CEA volume.
Outcomes were examined to track trends in complication rates.
Results: The annual number of CEA procedures increased 74% from 63.7 per 100,000
residents per year to 110.8 per 100,000 residents per year between 1992 and 1996. A
single large increase occurred during the second half of 1994 when CEAs increased
73.5% from 16.6 per 100,000 residents per quarter to 28.8 per 100,000 residents per
quarter after a clinical alert on benefits to CEAs in asymptomatic patients. Over 5 years,
there were significant trends toward more nonemergent admissions, and more proce-
dures were performed in high-volume hospitals and by high-volume surgeons.
Procedure rates in both women and very elderly patients increased more than 70%,
which was in step with younger patients and men. The incidence of inpatient stroke and
death declined over the 5-year period, whereas the rate of perioperative myocardial
infarction remained constant.
Conclusions: Experience from Florida indicates that CEA rates increased as results of the
Asymptomatic Carotid Artery Study disseminated. Trial results have been broadly inter-
preted to include women and very elderly patients. More patients are being referred to
busier hospitals and to high-volume surgeons, which should continue to result in better
patient outcomes. (J Vasc Surg 2000;31:901-9.)
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Asymptomatic Carotid Artery Study (ACAS)
restricted recruitment to patients aged 79 years or
younger. Furthermore, both the ACAS and the
moderate stenosis arm of the NASCET, in subgroup
analysis, could not demonstrate a significant benefit
for women or minorities. Because the margin of
benefit for CEA depends largely on low hospital
morbidity and mortality rates, questions have arisen
regarding the overall safety of the procedure because
these results are generalized to all institutions and to
all patient populations.7,8
Perioperative mortality has been shown to be
inversely proportional to procedure volume. As a
result, some authors have suggested that CEAs be
regionalized in specialized centers.9-12 Others have
suggested that CEAs be restricted to certain low-risk
or high-benefit patient populations, particularly
when treating patients with asymptomatic dis-
ease.8,13 This study, based on hospital administrative
data from the state of Florida, was undertaken to
characterize the increase in CEA frequency and pop-
ulation-based rates after the ACAS report in 1994.
We sought to detect alterations in referral patterns
and changes in the patient population to see how the
results of CEA trials affected patterns of clinical
practice. Finally, we reviewed outcome data seeking
concomitant changes in statewide results.
METHODS
Hospital UB92 discharge records for all Florida
nonfederal hospitals with a first-listed ICD-9 proce-
dure code of 38.12 were obtained from the Florida
Agency for Health Care Administration. Data on
CEA discharges from 1992 to 1996 (n = 45,744)
were extracted from this database and aggregated
quarterly to review trends over the study period.
Discharge records included age, sex, emergency
admission status, attending surgeon, and length of
stay, as well as secondary diagnoses and procedures.
Patient race and payer status, although available in
some instances, were incomplete for a large percent-
age of records and were therefore not included in
the analysis. Detailed clinical data, including the
indications for surgery and the degree of carotid
bifurcation stenosis, are unavailable from hospital
administrative databases.
In addition, hospital bed capacity, teaching status
(as measured by Council of Teaching Hospitals
membership or a hospital residency program), and
ownership characteristics (for profit, nonprofit, reli-
gious, and government) were derived from
American Hospital Association data. Total annual
hospital admissions for CEAs across any Florida hos-
pital were used to compute each surgeon’s annual
CEA volume. Florida population denominator esti-
mates were derived from the US Census Bureau
website projections for 1992-1995 to compute CEA
rates per 100,000 residents for each age group.
The Mantel-Haenszel χ2 test for trend was used
to compare the significance of annual changes over
the 5 years. Three sets of variables were examined.
First, the proportion of patients aged 80 years and
older, the proportion of female patients, and the
proportion of emergency admissions were contrast-
ed over the study period. Second, changes in the
annual proportion of CEA procedures performed at
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Fig 1. Quarterly Florida CEA procedures per 100,000 residents between 1992 and 1996.
ACAS, Asymptomatic Carotid Artery Study; CEA, carotid endarterectomy.
smaller hospitals (< 350 beds), teaching hospitals,
and private nonprofit (vs religious, government, and
proprietary) institutions were examined. Finally,
changes in the annual proportion of CEA proce-
dures at high-volume hospitals (> 100 CEA admis-
sions per year) and/or by high-volume surgeons (>
30 CEA procedures annually) were analyzed.
ICD-9 diagnosis codes were used to determine
the incidence of new nonfatal myocardial infarction
(MI) (410) or stroke (430, 431). Because iatrogenic
stroke codes were so rarely and inconsistently coded,
these particular complications were assumed to be
the result of surgical intervention rather than to 
be present in patients on admission. In-hospital
death was also determined from discharge status.
Complications that occurred within the 30-day peri-
operative period but outside the admitting facility
could not be identified. Trends in complication rates
over the 5-year study period were calculated and
tested for annual trends.
RESULTS
Fig 1 presents data for CEA admissions (n =
45,744) over the 20 quarters from the first quarter
of 1992 through the end of 1996. The annual num-
ber of CEA procedures increased 74% from 63.7
per 100,000 residents per year to 110.8 per
100,000 residents per year from 1992 to 1996. The
study time period clearly straddles a major increase
in total procedures occurring directly after the 1994
ACAS advisory.14 A single large increase occurred
during the second half of 1994 when CEAs
increased from 16.6 per 100,000 residents per
quarter to 28.8 per 100,000 residents per quarter,
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Fig 2. A, Florida quarterly CEA procedures per 100,000 residents by age category—men
(adjusted for age and sex). B, CEA procedures per quarter per 100,000 residents as percentage
of the 1992 first quarter cases—men (adjusted for age and sex). CEA, Carotid endarterectomy.
A
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an increase of 73.5% over the 6-month period after
the clinical alert.
Figs 2 and 3 display the male and female admis-
sion rates per 100,000 Florida residents stratified
into five age groups and the corresponding percent-
age increase over time compared with first quarter
(92-Q1) statistics. These quarterly trends indicate a
significant but fairly uniform increase among all
patients aged 65 years and older including patients
older than 80 years. Similarly, the percentage
increase in surgical procedures in women kept pace
with the increase in men. Over the entire 5 years
there was a 73.4% increase in CEA rates among the
female population, compared with a 74.2% increase
in the male population. The average number of pro-
cedures in patients aged 80 years and older rose 82%
between 1992 and 1996, compared with 58% for
patients aged 65 to 69 years, 81% for patients aged
70 to 74 years, and 70% for patients aged between
75 and 79 years.
This impression of a sharp increase in procedures
associated with a publication of 1994 trial results is
confirmed by the data in Table I, in which results of
χ2 tests for annual trends for the eight study vari-
ables are presented. There was a near doubling of
the overall number of CEA procedures over the peri-
od. The annual proportion of patients undergoing
CEAs who were female or aged 80 years and older
remained relatively stable over the study period with
rates increasing in step with younger male patients.
Although the trend for nonteaching hospitals was
significant and modestly upward, this change began
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Fig 3. A, Florida quarterly CEA procedures per 100,000 residents by age category—women
(adjusted for age and sex). B, CEA procedures per quarter per 100,000 residents as a per-
centage of the 1992 first quarter cases—women (adjusted for age and sex). 
A
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before the ACAS advisory and may not reflect the
effect of trial results. There were significant annual
increases in the proportion of nonemergent admis-
sions, especially for high-volume hospitals and sur-
geons that appear to be highly associated with the
1994 advisory letter.
Figs 4 and 5 present hospital and surgeon vol-
ume trends over the study period, and the corre-
sponding percentage increase compared with first
quarter (92-Q1) statistics is shown. Hospitals with
larger annual CEA volumes, especially hospitals with
more than 150 CEA admissions, had huge increases
in procedures, whereas hospitals with less than 50
CEA procedures annually showed a modest decline
over the 5-year period. Similarly, procedure volume
increased among the busiest CEA surgeons (> 30
CEA admissions) who increased their share of the
total procedure volume from just over 30% in 1992
to more than 60% in 1996.
Table II depicts annual trends in combined
major complications of inpatient MI, stroke, and
death. The combined rate went down significantly
from 9.0% in 1992 to 5.3% in 1996. Women and
very elderly patients also experienced significant
reductions in rates of complication. This decline was
driven by significantly reduced rates of stroke and
death; the rate of perioperative MI remained con-
stant over time. Complications were more common
among patients whose surgeons performed small
numbers of CEAs or were admitted to low-volume
hospitals. Although the trend toward fewer compli-
cations is significant, it should be noted that length
of stay was decreasing during these years as well, and
some proportion of any reduction may be due to
events occurring in the later days of stays in the ear-
lier years.
DISCUSSION
The indications for CEA have become clearer
after the publication of several large multicenter,
controlled clinical trials. In all but the poorest risk
patients who harbor symptomatic carotid bifurca-
tion stenosis, CEA appears to be both beneficial and
indicated. Similarly, surgery for asymptomatic
carotid stenosis appears to be beneficial in certain
well-defined patient populations. These large trials
were designed to show clinical efficacy and, justifi-
ably, were carried out under extremely narrow con-
ditions of surgeon, institution, and patient eligibili-
ty. In the NASCET, each institution had to maintain
at least 25 CEA procedures per year and a complica-
tion rate of less than 6%. Overall, trial institutions
comprised less than 4% of all hospitals offering
CEAs.7 In the ACAS, surgeons were required to
provide evidence demonstrating a less than 3% peri-
operative event rate before they were allowed to par-
ticipate in the trial. Additionally, each ACAS sur-
geon’s results were continually audited throughout
the trial, and each surgeon was potentially subject to
censure. Also, patients underwent rigorous evalua-
tion. More than 42,000 patients were screened to
enroll 1662 patients in the ACAS.2 In both the
NASCET and the ACAS, patients could only be ran-
domized if they were aged between 40 and 79 years,
had a 5-year life expectancy, and were free of unsta-
ble angina, atrial fibrillation, severe diabetes melli-
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Table I. Florida CEA admissions 1992-1996 annual trends in patient, hospital, and surgeon characteristics
as percentage of annual admissions (N = 45,744 admissions)
Year
1992 1993 1994 1995 1996 P value*
Number of CEA admissions 6620 6883 8240 11,797 12,204
Age ≥ 80 years y 18.8 19.2 17.9 17.7 17.8 .1657
Female 42.0 41.7 41.7 42.7 41.9 .9923
Emergency admission 10.7 10.5 10.0 8.2 8.2 < .0001
Hospital beds < 350 51.9 51.6 50.1 49.0 49.7 .0021
Nonteaching hospital† 79.0 81.3 81.5 81.4 81.7 .0085
Nonprofit hospital‡ 42.9 43.5 44.3 42.4 42.7 .8482
Low-volume hospital§ 74.3 71.8 58.2 36.0 30.0 < .0001
Low-volume surgeon 68.2 59.1 54.7 38.7 38.8 < .0001
*P < .05 indicates significant change in proportion during the study period as assessed by the χ2 test for trend.
†Compared with members of the Council of Teaching Hospitals or hospitals with residency training programs.
‡Compared with public, religious, and private proprietary hospitals.
§Compared with hospitals with > 100 CEA admissions per year.
Compared with surgeons with > 30 CEA admissions per year.
CEA, Carotid endarterectomy.
tus, uncontrolled hypertension, renal or hepatic
insufficiency, and cancer.
The effectiveness of CEA produced in the
NASCET and the ACAS is only directly applicable
outside the trials if patients with characteristics simi-
lar to those in the trials are operated on with repro-
ducible low risk. Trial collaborators have strongly
suggested that CEAs be limited to specialized cen-
ters of excellence and to surgeons who have clearly
demonstrated their expertise. Similar caution has
been urged when it comes to generalizing trial
results to women, minorities, and very elderly
patients.
A number of recent population-based studies
demonstrate that the excellent results generated in
the controlled clinical trials are not equally matched
in the community.9,15 It is estimated that one half of
all Medicare recipients who undergo CEAs do so in
hospitals with perioperative mortality rates exceed-
ing the average experience of the hospitals that par-
ticipated in the clinical trials.16 The literature also
suggests that in general, low-volume hospitals and
low-volume surgeons do not produce the same
high-quality results as higher-volume surgeons and
higher-volume hospitals.7,10-18 Although this rela-
tionship is complex, it would certainly appear that
inexperience leads to poorer results.
Population-based studies that had reviewed CEA
rates before the release of the NASCET and the
ACAS suggested that significant percentages were
being performed by surgeons and in institutions that
performed less than five CEAs per year.11,19-21
Using Medicare billing data, Hsia et al10 found that
during 1985-1989 when procedure rates were on
the decline, CEAs occurred more frequently in
urban and nonprofit institutions and that surgery
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Fig 4. A, CEA procedures per quarter by hospital volume. B, CEA cases by hospital volume
as a percentage of the 1992 first quarter cases.
A
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steadily moved to hospitals with lower-procedural
volumes. Data published by Manheim et al16 cor-
roborated this trend during the late 1980s and, con-
sistent with our data, showed a reversal of this trend
as the CEA procedure rate rebounded in the 1990s.
In addition, the randomized trials have provided
data that may be biased toward certain subsets of the
overall population. In these trials, large groups of
patients were screened to identify much smaller
numbers deemed appropriate for enrollment. By
protocol, the NASCET and the ACAS recruited a
younger, healthier subset of patients. Stukenborg21
has shown that a significant portion of Medicare
patients undergoing CEAs was dissimilar to trial par-
ticipants, with almost 30% having one or more
comorbid conditions that would have excluded
them. Similarly, Wennberg et al7 showed that
patients randomized in the trials were much younger
and much healthier than those in general practice
and that the operative risk for the average Medicare
patient substantially exceeded that experienced by
trial participants. They also noted that more than
15% of Medicare patients undergoing CEAs were
older than 80 years, above the age eligibility cutoff
for the trials. This group also showed that patients
older than 85 years were three times more likely to
die compared with those younger than 70 years.
Population-based data from New York and
California also indicate that there is a higher compli-
cation rate among elderly patients.9 Although Hsia
et al10 found no obvious demographic shift in the
composition of Medicare patients undergoing CEAs
nationwide, data from the state of Maryland cover-
ing the years 1990-1995 clearly documented a trend
toward treatment of an older patient population.
Consistent with our Florida 1990s data, Perler et
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Fig 5. A, CEA procedures per quarter by surgeon volume. B, CEA cases by surgeon volume
as a percentage of the 1992 first quarter cases.
A
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al13 demonstrated a trend toward improved out-
comes over the study period.
Also, for reasons that are unclear, the number of
women and multiracial minorities participating in the
trials was small. In fact, the ACAS was unable to pro-
duce significant data to justify CEAs in women and
in certain minorities because of inadequate patient
enrollment. Significant ambiguity remains regarding
surgical indications within these subpopulations.
We were able to show that in the state of Florida
the rate of increase appeared to be evenly distributed
between the sexes and across all age distributions.
This means that rate increases occurred in women
and in patients older than 80 years with the same fre-
quency as rates did in known lower-risk groups. We
did, however, find evidence to suggest that patients
are being referred to higher-volume hospitals and to
higher-volume surgeons. Our findings are consistent
with Maryland population-based data that also sug-
gest that regionalization is occurring and that out-
comes are improving as a result, although caution is
required in comparing inpatient event rates during a
period of falling length of stay. This may indicate
that referring physicians have responded to the liter-
ature indicating that experience leads to better
results. The decline in stroke and death rates in
Florida may be a reflection of this trend toward
regionalization. However, it is unclear whether the
improvement in outcomes is a result of the change
in referral patterns or the result of an increase in
surgery within the lower-risk asymptomatic popula-
tion. This is in contrast to the population-based data
published by Tu et al9 that identified high mortality
rates in California, New York, and Ontario where
patients continued to be referred to hospitals with
historically low volumes and high mortality rates.
They attributed this to a lack of awareness of local
stroke and death rates with patient referrals based on
availability and convenience rather than outcomes.
There are a number of well-recognized limita-
tions to using hospital administrative data.
Discharge diagnosis and procedure codes may not
be completely reliable because of miscoding or
incomplete data. Also, when codes for stroke or for
MI are identified, these complications are assumed
to be coded correctly as new incident events related
to surgery rather than to being present preopera-
tively. This may not always be true, particularly with
stroke, which may be the indication for, rather than
the result of, surgery. Furthermore, because the
database identifies only in-hospital morbidity and
mortality, information regarding complications that
occur after discharge to home or deaths that take
place after transfer to other facilities is not captured
in this type of a database. We have previously shown
that hospital length of stay also declined over the
same time period. As such, complication rates may
be underestimated, and the trends implicating
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Table II. Florida CEA admissions 1992-1996 annual trends in major complications as percentage of annu-
al admissions: inpatient stroke, MI, or death (N = 45,744)
Year
1992 1993 1994 1995 1996 P value*
Number of CEA admissions 6620 6883 8240 11,797 12,204
All—combined 9.0 8.9 6.5 5.1 5.3 < .0001
All—stroke 7.3 7.6 5.1 3.8 4.0 < .0001
All—MI 0.9 0.7 0.8 0.7 0.7 .9476
All—death 1.1 0.9 0.8 0.7 0.7 .0039
Combined events
Age ≥ 80 y 10.6 12.0 8.7 6.8 6.3 < .0001
Female 9.7 8.5 6.4 5.0 5.2 < .0001
Emergency admission 21.7 20.2 16.6 15.7 15.6 < .0001
Hospital beds < 350 9.1 9.2 6.8 5.6 5.6 < .0001
Nonteaching hospital† 9.1 9.2 6.8 5.1 5.2 < .0001
Nonprofit hospital‡ 9.5 8.7 6.4 5.2 5.2 < .0001
Low-volume hospital§ 9.6 9.3 7.2 5.6 6.7 < .0001
Low-volume surgeon 9.8 9.4 7.2 5.7 6.8 < .0001
*P < .05 indicates significant change in proportion during the study period as assessed by the χ2 test for trend.
†Compared with members of the Council of Teaching Hospitals or hospitals with residency training programs.
‡Compared wtih public, religious, and private proprietary hospitals.
§Compared with hospitals with > 100 CEA admissions per year.
Compared with surgeons with > 30 CEA admissions per year.
CEA, Carotid endarterectomy; MI, myocardial infarction.
improvement in outcomes over time may be biased
by concomitant trends toward earlier discharge or
transfer.12 Also, administrative records provide no
information about degree of carotid stenosis and
only indirect information regarding the indications
for surgery and significant patient comorbidity. If
more asymptomatic patients are undergoing surgery,
it is possible that outcomes have improved because
asymptomatic patients have inherently lower risk.
After some years of decline, the number of CEAs
performed in this country is again increasing dramat-
ically. Volume increased 74% between 1992 and
1996 in this study from the state of Florida. In New
York, CEA volume rose 176% over the time period
from 1990 to 1995 that encompassed the release of
both the NASCET and the ACAS.22 The recent wave
of enthusiasm for CEA is undoubtedly driven by the
dissemination of trial data supporting its continued
use.1,13,17,23,24 Sharp rate upswings followed closely
on the heels of each trial publication because these
results were rapidly disseminated to nontrial surgeons
in the community. In the present study, the most dra-
matic rate increase of more than 73% occurred over a
6-month time period immediately after the publica-
tion of the ACAS clinical alert. In general, it remains
unclear whether the increase has occurred only in the
subset of patients known to derive benefit as defined
by the randomized trials or if indications have been
liberalized in the community. Furthermore, it is
unknown whether patients are experiencing the full
benefits of CEA by undergoing surgery in high-vol-
ume institutions and by experienced surgeons with
documented low stroke and death rates. Regardless,
the trends identified in Florida are relatively clear,
and at least in that state, a broad segment of the pop-
ulation is being treated with improved outcomes,
perhaps as a result of improving referral patterns.
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